Drug Shortage Report for SODIUM THIOSULFATE INJECTION USP

Last updated on 2020-01-14 History
Report ID 94406
Drug Identification Number 02428393
Brand name SODIUM THIOSULFATE INJECTION USP
Common or Proper name Sodium Thiosulfate Injection USP
Company Name HOPE PHARMACEUTICALS LTD
Market Status MARKETED
Active Ingredient(s) SODIUM THIOSULFATE
Strength(s) 250MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 1 x 50 mL Vials
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2019-09-25
Actual start date 2019-09-27
Estimated end date 2020-01-13
Actual end date 2020-01-13
Shortage status Resolved
Updated date 2020-01-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 422 RICHARDS STREET
VANCOUVER, BRITISH COLUMBIA
CANADA V6B 2Z4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2020-01-14 English Compare
v17 2020-01-13 French Compare
v16 2020-01-13 English Compare
v15 2020-01-13 French Compare
v14 2020-01-13 English Compare
v13 2020-01-13 English Compare
v12 2020-01-13 English Compare
v11 2020-01-13 French Compare
v10 2020-01-13 English Compare
v9 2020-01-13 English Compare
v8 2019-09-28 French Compare
v7 2019-09-28 English Compare
v6 2019-09-28 English Compare
v5 2019-09-28 English Compare
v4 2019-09-26 English Compare
v3 2019-09-19 French Compare
v2 2019-09-19 English Compare
v1 2019-09-19 English Compare

Showing 1 to 18 of 18